A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Public ClinicalTrials.gov record NCT03656744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM
Study identification
- NCT ID
- NCT03656744
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- HighTide Biopharma Pty Ltd
- Industry
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Interventions
- HTD1801 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2018
- Primary completion
- Feb 6, 2020
- Completion
- Mar 8, 2020
- Last update posted
- Dec 28, 2021
2018 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Institute for Liver Health | Chandler | Arizona | 85224 | — |
| Institute for Liver Health | Tucson | Arizona | 85711 | — |
| Adobe Clinical Research | Tucson | Arizona | 85712 | — |
| National Research Institute | Panorama City | California | 91402 | — |
| Excel Medical Clinical Trials | Boca Raton | Florida | 33434 | — |
| Florida Research Institute | Lakewood Rch | Florida | 34211 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Kansas City Research Institute | Kansas City | Missouri | 64131 | — |
| Cumberland Research Associates | Fayetteville | North Carolina | 28304 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Digestive Health Research | Hermitage | Tennessee | 37076 | — |
| Pinnacle Clinical Research | Austin | Texas | 78746 | — |
| Doctors Hospital at Renaissance | Edinburg | Texas | 78539 | — |
| Pinnacle Clinical Research | San Antonio | Texas | 78229 | — |
| Texas Digestive Disease Consultants | Southlake | Texas | 76092 | — |
| Harborview Medical Center | Seattle | Washington | 98195 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03656744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03656744 live on ClinicalTrials.gov.